Results 31 to 40 of about 5,472 (197)
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome [PDF]
Clinical and Molecular Hepatology, 2013 Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does ...
Hae Rim Kim +13 more
doaj +1 more source
Two-component vasopressor therapy for septic shock
Вестник анестезиологии и реаниматологии, 2021 The objective: to investigate the efficacy and safety of terlipressin when it is used as an additional vasopressor in septic shock.Subjects: A single-center, observational, retrospective-prospective study of the efficacy and safety of combined therapy of
A. A. Kochkin +2 more
doaj +1 more source
It is reasonable to treat patients with type 1 hepatorenal syndrome with midodrine and octreotide [PDF]
, 2016 A critical appraisal and clinical application of Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007;
Kane, William
core +2 more sources
Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites [PDF]
, 2019 Background: bioelectrical impedance analysis is a technique for the determination of the hydropic component. The hydropic component, determined by blood volume, could be a reflection of the hemodynamic situation.
Ampuero Herrojo, Javier +4 more
core +5 more sources
Terlipressin Induced Severe Hyponatremia
Prague Medical Report, 2016 Terlipressin is a vasopressin analogue used for its vasoconstrictor effect in the treatment of variceal bleeding. Despite its good safety profile compared to vasopressin, some adverse reactions may occur during its use – e.g. hyponatremia.
Martin Šíma +3 more
doaj +1 more source
GastroHep, 2022 Background. Terlipressin is a long acting synthetic analogue of vasopressin, which is used to manage variceal bleeding and hepatorenal syndrome.
Jasmohan S. Bajaj +8 more
doaj +1 more source
Gastroenterology Insights, 2023 Hepatorenal syndrome stands as one of several potential triggers of acute kidney injury in individuals grappling with either acute or persistent liver ailments. The nature of the decline in kidney function has led to the identification of two variants of
Ahlam Ayyad, Rami A. Al-Horani
doaj +1 more source
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study [PDF]
, 2013 AIM: To investigate clinical and biochemical features of hepatorenal syndrome (HRS), to assess short and long-term survival evaluating potential predictors of early mortality. METHODS: Sixty-two patients with liver cirrhosis and renal failure, defined as
Almasio, P. +6 more
core +1 more source
Gastro Hep Advances, 2023 Background and Aims: Type 1 hepatorenal syndrome (HRS) is a rapid deterioration in kidney function in patients with cirrhosis. Data on efficacy of vasoconstrictors for type 1 HRS have shown mixed results.
Ashwani K. Singal +4 more
doaj +1 more source
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update [PDF]
, 2010 Refractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. Large volume paracentesis and pleurodesis are regarded as first-line treatments in patients who do not respond ...
Gerbes, Alexander L., Roessle, Martin
core +1 more source